Cardior Pharmaceuticals picks up $76m Series B

Cardior Pharmaceuticals, a developer of non-coding RNA-based therapeutics for patients with cardiac diseases, has raised $76 million in Series B financing.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this